Search for " " - 2/462

Results for “ ”

Entry	Author	Date	Location
Data in Hand, Alnylam to Seek OK for Second RNAi Drug	Ben Fidler	03/06/19	Boston
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs	Corie Lok	03/06/19	Boston
Two Years and Done: FDA Commissioner Gottlieb To Resign	Alex Lash	03/05/19	National
Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples	Jeff Buchanan	03/05/19	Seattle
Angel Networks Most Active Texas Investors Since 2010, Report Says	David Holley	03/05/19	Texas
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount	Frank Vinluan	03/04/19	Indiana
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy	Frank Vinluan	03/04/19	Raleigh Durham
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar	Ben Fidler	03/04/19	Boston
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future	Corie Lok	03/01/19	National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark	Ben Fidler	03/01/19	National
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease	Sarah de Crescenzo	02/28/19	San Diego
7 Tips for Biotech Companies Seeking Capital in a Volatile Market	Cynthia Mazareas and Craig Hilts	02/28/19	National
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans	Frank Vinluan	02/28/19	San Francisco
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases	Alex Lash	02/28/19	San Francisco
Kaleido Bio Downsizes IPO, Raises $75M for Microbiome Drug Tests	Frank Vinluan	02/27/19	Boston
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington	Frank Vinluan	02/27/19	New York
Sarepta Touts More Gene Therapy Data, Snaps Up Myonexus For $165M	Ben Fidler	02/27/19	Boston
Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug	Ben Fidler	02/27/19	Boston
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away	Alex Lash	02/26/19	National
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO	David Holley	02/26/19	Texas
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer	Ben Fidler	02/26/19	New York
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray	Ben Fidler	02/26/19	New York
Ginkgo’s Motif Launches with $90M for Animal-Free Meat & Milk Proteins	Frank Vinluan	02/26/19	Boston
Novartis to Pay $150M to Ionis, Akcea for Drug to Slow Heart Disease	Sarah de Crescenzo	02/25/19	San Diego
Bill Maris’s VC Firm Section 32 Raises $200M for Second Fund	Sarah de Crescenzo	02/25/19	San Diego
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy	Ben Fidler	02/25/19	National
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns	Frank Vinluan	02/22/19	Boston
Exact Sciences Eyes Cologuard Market Expansion After “Landmark Year”	Jeff Engel	02/22/19	Wisconsin
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact	Frank Vinluan	02/22/19	Boston
WI Watchlist: Rockwell, Wellbe, Generac, API Healthcare & More	Jeff Engel	02/22/19	Wisconsin
Page 2 of 367	« previous page · next page »